Total Hip Replacement Unilateral
Item
(1) individuals undergoing unilateral total hip replacement with the conserve®
boolean
C0040508 (UMLS CUI [1,1])
C0205092 (UMLS CUI [1,2])
Acetabular Hip Joint Prostheses | Femoral Head Prosthesis | Femoral stem prosthesis
Item
acetabular component and the conserve® a-class bfhä femoral head in combination with an uncemented femoral stem produced from the ti-6a1-4v alloy (astm f-136) with or without titanium plasma coating.
boolean
C0182473 (UMLS CUI [1])
C0015803 (UMLS CUI [2])
C1304657 (UMLS CUI [3])
Hip surgery Primary Osteoarthritis of hip | Degenerative polyarthritis | Traumatic arthropathy | Hip Dislocation, Congenital | Avascular necrosis
Item
(2) patients who are undergoing primary hip surgery for noninflammatory degenerative joint disease (nidjd). composite diagnoses of nidjd include osteo/degenerative arthritis, traumatic arthritis, congenital hip dysplasia, and avascular necrosis.
boolean
C0596706 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0029410 (UMLS CUI [1,3])
C0029408 (UMLS CUI [2])
C0152086 (UMLS CUI [3])
C0019555 (UMLS CUI [4])
C3887513 (UMLS CUI [5])
Age | Skeletal maturity | Protocol Compliance | Clinical Study Follow-up Postoperative Period | annual; examination
Item
(3) patients 18 years of age or older (skeletally mature). (4) patients for whom there is a reasonable expectation that they will be available for each examination scheduled over a two year post-operative follow-up period and for annual exams until the last patient entered into the study has achieved two years of follow-up.
boolean
C0001779 (UMLS CUI [1])
C3825673 (UMLS CUI [2])
C0525058 (UMLS CUI [3])
C3274571 (UMLS CUI [4,1])
C0032790 (UMLS CUI [4,2])
C1401325 (UMLS CUI [5])
Informed Consent
Item
(5) patients who agree to participate and sign the informed consent form. (6) patients who do not meet any of the exclusion criteria.
boolean
C0021430 (UMLS CUI [1])
Fusion procedure | Femoral Neck Fractures | Amputation above Knee | arthritic change Knee
Item
(1) patients with previous fusions, acute femoral neck fractures, above knee amputations, or significant arthritic changes to the knees.
boolean
C1293131 (UMLS CUI [1])
C0015806 (UMLS CUI [2])
C0002688 (UMLS CUI [3,1])
C1282910 (UMLS CUI [3,2])
C0022742 (UMLS CUI [3,3])
C0741221 (UMLS CUI [4,1])
C0022742 (UMLS CUI [4,2])
Communicable Disease | Nervous system disorder Affecting Gait | Musculoskeletal Disease Affecting Gait | Nervous system disorder Affecting Weight Bearing | Musculoskeletal Disease Affecting Weight Bearing
Item
(2) patients with evidence of active infection. (3) patients with neurologic or musculoskeletal disease that may adversely affect gait or weight-bearing.
boolean
C0009450 (UMLS CUI [1])
C0027765 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0016928 (UMLS CUI [2,3])
C0026857 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0016928 (UMLS CUI [3,3])
C0027765 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0085086 (UMLS CUI [4,3])
C0026857 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0085086 (UMLS CUI [5,3])
Resurfacing Hemi Ipsilateral | Resurfacing Total | HIP ARTHROPLASTY BIPOLAR | HIP ARTHROPLASTY UNIPOLAR | Total hip replacement prosthesis
Item
(4) patients who have previously undergone an ipsilateral hemi resurfacing, total resurfacing, total bipolar, unipolar or total hip replacement device.
boolean
C0444754 (UMLS CUI [1,1])
C1285521 (UMLS CUI [1,2])
C0441989 (UMLS CUI [1,3])
C0444754 (UMLS CUI [2,1])
C0439810 (UMLS CUI [2,2])
C0744913 (UMLS CUI [3])
C0744916 (UMLS CUI [4])
C0302751 (UMLS CUI [5])
Neuropathic joints | Mental disorder Severe | Bone Transplantation Patient need for | Hypersensitivity Cobalt-Chromium-Molybdenum Alloy | Excision arthroplasty of the hip Ipsilateral | Anemia, Sickle Cell | Kidney Failure | Creatinine measurement, serum
Item
(5) patients with neuropathic joints. (6) patients with severe documented psychiatric disease. (7) patients requiring structural bone grafts. (8) patients with a documented allergy to cobalt chromium molybdenum. (9) patients with an ipsilateral girdlestone. (10) patients with sickle cell disease. (11) patients with renal failure as defined by serum creatinine level greater than 180 fmol/l.
boolean
C0149739 (UMLS CUI [1])
C0004936 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0005976 (UMLS CUI [3,1])
C0686904 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0205998 (UMLS CUI [4,2])
C0408397 (UMLS CUI [5,1])
C0441989 (UMLS CUI [5,2])
C0002895 (UMLS CUI [6])
C0035078 (UMLS CUI [7])
C0201976 (UMLS CUI [8])
Informed Consent Refused
Item
(12) patients who otherwise meet the study criteria, but refuse to consent in writing to participate in the study.
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])